Hedge Fund Citadel takes short position in GSK, FT reports
Hedge fund Citadel has made a 305 million pound ($384.5 million) bet against drugmaker GSK , the Financial Times reported on ...
Citadel takes $384.5 million short position in GSK - FT
Citadel, the hedge fund owned by billionaire Ken Griffin, has taken a short position in GlaxoSmithKline (NYSE:GSK), a British ...
Citadel's Griffin sees tariffs posing risk to US growth
Ken Griffin, founder and CEO of investment firm Citadel, said on Tuesday that U.S. President Donald Trump's tariff policy is ...
Financial Advisor7d
Citadel Gives Rare Glimpse Of $57 Billion Gains From Its Largest Funds
The firm's $1 billion bond offering required Ken Griffin's secretive hedge fund to produce a prospectus for investors.
Ken Griffin's multistrategy hedge fund at Citadel rose 1.4% in volatile January
Citadel's multistrategy flagship Wellington fund climbed 1.4% in January, following a 15.1% gain in 2024, according to the ...